MathiasR., SaluskyI., HarmanW., ParedesA., EmansJ., SegreG.Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital.J Am Soc Nephrol1993; 3: 1938–46.
2.
GroothoffJ.W., OffringaM., Van Eck-SmitB.L., GruppenM.P., Van De KarN.J., WolffE.D.Severe bone disease and low bone mineral density after juvenile renal failure.Kidney Int2003; 63: 266–75.
3.
CanoF.J., AzocarM.A., GuerreroJ.L., DelucchiM.A., LilloA.M., EmilforkM.Intraperitoneal calcitriol in infants on peritoneal dialysis.Perit Dial Int2007; 27: 681–6.
SaluskyI.B., KuizonB.D., BelinT.R., RamirezJ.A., GalesB., SegreG.V.Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration.Kidney Int1998; 54: 907–14.
6.
SaluskyI.B., GoodmanW.G., HorstR., SegreG.V., KimL., NorrisK.C.Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients.Am J Kidney Dis1990; 16: 126–32.
7.
QuarlesL.D., HartleJ.E., MiddletonJ.P., ZhangJ., ArthurJ.M., RaymondJ.R.Aluminum-induced DNA synthesis in osteoblasts: mediation by a G-protein coupled cation sensing mechanism.J Cell Biochem1994; 56: 106–17.
8.
GroothoffJ.W., LilienM.R., van de KarN.C., WolffE.D., DavinJ.C.Cardiovascular disease as a late complication of end-stage renal disease in children.Pediatr Nephrol2005; 20: 374–9.
9.
GruppenM.P., GroothoffJ.W., PrinsM., van der WouwP., OffringaM., BosW.J.Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study.Kidney Int2003; 63: 1058–65.
10.
SaluskyI.B., GoodmanW.G., SahneyS., GalesB., PerillouxA., WangH.J.Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.J Am Soc Nephrol2005; 16: 2501–8.
11.
KlausG., MehlsO., HindererJ., RitzE.Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?Lancet1991; 337(8744): 800–1.
12.
CanoF., DelucchiA., WolffE., RodriguezE., FuentesA.Calcitriol oral pulse therapy in children with renal osteodystrophy.Pediatr Nephrol1995; 9: 606–8.
13.
K/DOQI Clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease.Am J Kidney Dis2005; 46(4 Suppl 1): S1–121.
14.
WallerS.C., RidoutD., CantorT., ReesL.Parathyroid hormone and growth in children with chronic renal failure.Kidney Int2005; 67: 2338–45.
15.
WallerS., LedermannS., TrompeterR., van'tH.W., RidoutD., ReesL.Catch-up growth with normal parathyroid hormone levels in chronic renal failure.Pediatr Nephrol2003; 18: 1236–41.
16.
SchmittC.P., ArdissinoG., TestaS., Claris-AppianiA., MehlsO.Growth in children with chronic renal failure on intermittent versus daily calcitriol.Pediatr Nephrol2003; 18: 440–4.
17.
KuizonB.D., GoodmanW.G., JüppnerH., BoechatI., NelsonP., GalesB.Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD.Kidney Int1998; 53: 205–11.
18.
WassnerS.J., AbitbolC., AlexanderS., ConleyS., GrupeW.E., HollidayM.A.Nutritional requirements for infants with renal failure.Am J Kidney Dis1986; 7: 300–5.
